These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 24689969)

  • 1. Elevated plasma YKL-40 as a prognostic indicator in patients with idiopathic pulmonary arterial hypertension.
    Chen G; Yang T; Gu Q; Ni XH; Zhao ZH; Ye J; Meng XM; Liu ZH; He JG; Xiong CM
    Respirology; 2014 May; 19(4):608-15. PubMed ID: 24689969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct bilirubin: A new risk factor of adverse outcome in idiopathic pulmonary arterial hypertension.
    Xu XQ; Lv ZC; Liu QQ; Zhao QH; Wu Y; Sun K; Jiang X; Wang L; Peng FH; Jing ZC
    Int J Cardiol; 2017 Feb; 228():895-899. PubMed ID: 27894061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood urea nitrogen to serum albumin ratio as a new indicator of disease severity and prognosis in idiopathic pulmonary artery hypertension.
    Zhang S; Gao L; Zhao Z; Zhao Q; Yang T; Zeng Q; Zhang Y; Li X; Huang Z; Duan A; Luo Q; Liu Z
    Respir Med; 2024 Jun; 227():107643. PubMed ID: 38657739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet distribution width and mean platelet volume in idiopathic pulmonary arterial hypertension.
    Zheng YG; Yang T; Xiong CM; He JG; Liu ZH; Gu Q; Zhao ZH; Ni XH
    Heart Lung Circ; 2015 Jun; 24(6):566-72. PubMed ID: 25573235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: a prognostic study within the CLARICOR trial.
    Harutyunyan M; Gøtze JP; Winkel P; Johansen JS; Hansen JF; Jensen GB; Hilden J; Kjøller E; Kolmos HJ; Gluud C; Kastrup J
    Immunobiology; 2013 Jul; 218(7):945-51. PubMed ID: 23294528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma MMP2/TIMP4 Ratio at Follow-up Assessment Predicts Disease Progression of Idiopathic Pulmonary Arterial Hypertension.
    Wetzl V; Tiede SL; Faerber L; Weissmann N; Schermuly RT; Ghofrani HA; Gall H
    Lung; 2017 Aug; 195(4):489-496. PubMed ID: 28516393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum YKL-40 predicts adverse clinical outcomes in patients with chronic heart failure.
    Bilim O; Takeishi Y; Kitahara T; Ishino M; Sasaki T; Suzuki S; Shishido T; Kubota I
    J Card Fail; 2010 Nov; 16(11):873-9. PubMed ID: 21055651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.
    Fijalkowska A; Kurzyna M; Torbicki A; Szewczyk G; Florczyk M; Pruszczyk P; Szturmowicz M
    Chest; 2006 May; 129(5):1313-21. PubMed ID: 16685024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inflammatory biomarker YKL-40 as a new prognostic marker for all-cause mortality in patients with heart failure.
    Harutyunyan M; Christiansen M; Johansen JS; Køber L; Torp-Petersen C; Kastrup J
    Immunobiology; 2012 Jun; 217(6):652-6. PubMed ID: 22209156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension.
    Rhodes CJ; Wharton J; Howard LS; Gibbs JS; Wilkins MR
    Heart; 2011 Jul; 97(13):1054-60. PubMed ID: 21558476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal pro-B-type natriuretic peptide-ratio predicts mortality after transcatheter aortic valve replacement.
    Stähli BE; Gebhard C; Saleh L; Falk V; Landmesser U; Nietlispach F; Maisano F; Lüscher TF; Maier W; Binder RK
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1240-7. PubMed ID: 25511571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma YKL-40 levels are elevated in patients with chronic heart failure.
    Rathcke CN; Kistorp C; Raymond I; Hildebrandt P; Gustafsson F; Lip GY; Faber J; Vestergaard H
    Scand Cardiovasc J; 2010 Apr; 44(2):92-9. PubMed ID: 19961288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of right ventricular ejection/filling parameters in IPAH using cardiac magnetic resonance: A prospective pilot study.
    Li W; Yang T; Zhang Y; Gu Q; Liu ZH; Ni XH; Luo Q; Xiong CM; He JG
    Respirology; 2017 Jan; 22(1):172-178. PubMed ID: 27442028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Echocardiography in pediatric pulmonary arterial hypertension: early study on assessing disease severity and predicting outcome.
    Ploegstra MJ; Roofthooft MT; Douwes JM; Bartelds B; Elzenga NJ; van de Weerd D; Hillege HL; Berger RM
    Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YKL-40, a novel marker of cardiovascular complications, is related to kidney function in heart transplant recipients.
    Przybyłowski P; Janik L; Wasilewski G; Nowak E; Koźlik P; Małyszko J
    Transplant Proc; 2014 Oct; 46(8):2860-3. PubMed ID: 25380936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low grade inflammation as measured by levels of YKL-40: association with an increased overall and cardiovascular mortality rate in an elderly population.
    Rathcke CN; Raymond I; Kistorp C; Hildebrandt P; Faber J; Vestergaard H
    Int J Cardiol; 2010 Aug; 143(1):35-42. PubMed ID: 19223085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum YKL-40 levels as a prognostic factor in patients with intracerebral hemorrhage.
    Jiang YX; Zhang GH; Wang ZM; Yang H
    Clin Biochem; 2014 Dec; 47(18):302-6. PubMed ID: 25262987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population.
    Zhu Q; Xiao W; Bai Y; Ye P; Luo L; Gao P; Wu H; Bai J
    Clin Interv Aging; 2016; 11():245-53. PubMed ID: 27013868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum human epididymis protein 4 level as a predictor of clinical worsening in idiopathic pulmonary arterial hypertension: a pilot study.
    Jin Q; Tang Y; Liu Z; Xie W; Luo Q; Zhao Z; Zhao Q; Huang Z; Yu X; Yan L; Xiong C; Ni X; Yan Y
    BMC Cardiovasc Disord; 2020 Apr; 20(1):175. PubMed ID: 32295533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension.
    Andreassen AK; Wergeland R; Simonsen S; Geiran O; Guevara C; Ueland T
    Am J Cardiol; 2006 Aug; 98(4):525-9. PubMed ID: 16893710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.